Search

Your search keyword '"Wendel, Hans-Guido"' showing total 390 results

Search Constraints

Start Over You searched for: Author "Wendel, Hans-Guido" Remove constraint Author: "Wendel, Hans-Guido"
390 results on '"Wendel, Hans-Guido"'

Search Results

3. EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC

5. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

6. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing

9. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

12. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

13. Data from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

14. Supplementary Figures and Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

15. Supplementary Table S5 from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

16. Supplementary Data from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

17. Supplementary Table 3 from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

18. Supplementary Table S3 from EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

19. Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

20. Data from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

21. Data from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

22. Figure S1, Figure S2, Figure S3, Figure S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

23. Supplementary Figures S1 - S14 from CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

24. Table S1, Table S2, Table S3, Table S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

25. Supplementary Table 4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

26. Supplementary Table 2 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

27. Supplementary figure S4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

28. Supplementary Table 1 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

29. Supplementary Table 3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

32. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia

34. TPX2 as Key Downstream Target of the eIF4A Controlled Translational Program in MYCN Driven Neuroblastoma

39. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

40. Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection

46. The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma

48. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity

Catalog

Books, media, physical & digital resources